Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Intangibles: 2011-2020

Historic Intangibles for UNITED THERAPEUTICS (UTHR) over the last 6 years, with Mar 2020 value amounting to $128.9 million.

  • UNITED THERAPEUTICS's Intangibles fell 6.39% to $128.9 million in Q1 2020 from the same period last year, while for Mar 2020 it was $128.9 million, marking a year-over-year decrease of 6.39%. This contributed to the annual value of $128.9 million for FY2019, which is 6.39% down from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Intangibles stood at $128.9 million for Q1 2020, which was down 0.00% from $128.9 million recorded in Q4 2019.
  • In the past 5 years, UNITED THERAPEUTICS's Intangibles ranged from a high of $137.7 million in Q3 2018 and a low of $21.5 million during Q1 2016.
  • For the 3-year period, UNITED THERAPEUTICS's Intangibles averaged around $132.7 million, with its median value being $128.9 million (2020).
  • Its Intangibles has fluctuated over the past 5 years, first spiked by 352.96% in 2018, then declined by 6.39% in 2019.
  • Over the past 5 years, UNITED THERAPEUTICS's Intangibles (Quarterly) stood at $21.5 million in 2016, then skyrocketed by 41.40% to $30.4 million in 2017, then surged by 352.96% to $137.7 million in 2018, then dropped by 6.39% to $128.9 million in 2019, then decreased by 6.39% to $128.9 million in 2020.
  • Its last three reported values are $128.9 million in Q1 2020, $128.9 million for Q4 2019, and $128.9 million during Q3 2019.